To conclude, CRP levels reflect only a part of the cancer-associated inflammation in patients with head and neck squamous cell carcinoma, and other acute phase cytokine mediators should be further investigated, both as possible prognostic biomarkers in these patients, as well as to improve the understanding of carcinogenesis in this malignancy. The gene discussed is CRP; the disease is head and neck squamous cell carcinoma.